Kidney Transplantation
📧 Sign up to get email alerts when something new happens for Kidney Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: Magnesium Replacement and Hyperglycemia After Kidney Transplantation [Phase 1, Phase 2]
Clinical trial update exploring magnesium replacement and hyperglycemia after kidney transplantation in Phase 1/2.
-
CLINICAL_TRIALS trial_result · 2021-06-24Clinical Trial Update: Ultra-low Dose Subcutaneous IL-2 in Renal Transplantation [Phase 1, Phase 2]
A phase 1/2 study of ultra-low dose subcutaneous interleukin-2 in kidney transplantation was terminated; results were posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-22Clinical Trial Update: Regimen Optimization Study [Phase 2]
Phase 2 regimen optimization study in kidney transplantation has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2021-03-09Clinical Trial Update: Effect of Privigen Against Graft Loss [Phase 3]
Phase 3 trial evaluating Privigen for prevention of graft loss in kidney transplant recipients has been completed.
-
CLINICAL_TRIALS trial_result · 2021-03-08Clinical Trial Update: Transversus Abdominis Plane Catheter Following Kidney Transplantation [Phase 3]
Phase 3 clinical trial update for a transversus abdominis plane catheter used after kidney transplantation to manage postoperative pain.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Standard Induction With Basiliximab Versus No-Induction in Low Immunological Risk Kidney Transplant Recipients [Phase 4]
Phase 4 clinical trial comparing standard induction with basiliximab versus no induction in low immunological risk kidney transplant recipie…
-
CLINICAL_TRIALS trial_result · 2021-01-08Clinical Trial Update: OPTImization of the Dose of tacroliMUS by Bayesian Prediction [Phase 4]
Phase 4 trial updating optimal tacroliMUS dosing using Bayesian prediction in kidney transplant patients has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-08Clinical Trial Update: Efficacy and Safety of Sirolimus Plus CNI Compared With MMF Plus CNI in ABO-i Kidney Transplant Recipients. [Phase 4]
Phase 4 trial comparing sirolimus plus calcineurin inhibitor versus mycophenolate plus calcineurin inhibitor in ABO-incompatible kidney tran…
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based [Phase 3]
Phase 3 trial in maintenance kidney transplant recipients after conversion to belatacept (Nulojix) completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: Efficacy and Safety of AEB071 Versus Tacrolimus in Combination With Mycophenolate Acid Sodium, Basiliximab and Steroids in Preventing Acute Rejection After Kidney Transplantation [Phase 1, Phase 2]
Phase 1/2 trial comparing AEB071 vs tacrolimus with mycophenolate, basiliximab and steroids for acute rejection prevention in kidney transpl…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients [Phase 1, Phase 2]
Phase 1/2 trial update evaluating AEB071 in combination with tacrolimus (converted to mycophenolic acid after 3 months) for kidney transplan…
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: Calcineurin Inhibitor Sparing After Kidney Transplantation [Phase 1, Phase 2]
Phase 1/2 trial evaluating strategies to spare calcineurin inhibitors after kidney transplantation to reduce CNI-related side effects.
-
CLINICAL_TRIALS trial_result · 2020-12-01Clinical Trial Update: Kidney Biopsy Controlled Trial of Calcineurin Inhibitor Withdrawal [Phase 4]
Phase 4 clinical trial evaluating withdrawal of calcineurin inhibitors in kidney transplant recipients has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-27Clinical Trial Update: Study Evaluating Conversion From Tacrolimus to Sirolimus in Stable Kidney Transplant Recipients Receiving Myfortic [Phase 4]
Phase 4 trial evaluating conversion from tacrolimus to sirolimus in stable kidney transplant recipients on mycophenolic acid (Myfortic).
-
CLINICAL_TRIALS trial_result · 2020-09-18Clinical Trial Update: Bela 8 Week Dosing [Phase 4]
Phase 4 clinical trial update for Bela 8-week dosing in kidney transplantation; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-22Clinical Trial Update: RituxiMab INDuction in Renal Transplantation [Phase 4]
Phase 4 trial update for RituxiMab induction therapy in renal transplantation; status is unknown.
-
CLINICAL_TRIALS trial_result · 2020-06-29Clinical Trial Update: To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant Recipients [Phase 4]
Phase 4 clinical trial comparing immediate-release tacrolimus (Prograf) and Astagraf XL to assess donor-specific antibody formation and immu…
-
CLINICAL_TRIALS trial_result · 2020-05-13Clinical Trial Update: Veloxis de Novo Kidney Transplant ECSWD [Phase 4]
A Phase 4 clinical trial update for Veloxis involving de novo kidney transplant patients, status currently unknown.
-
CLINICAL_TRIALS trial_result · 2020-05-08Clinical Trial Update: Measurements of Kidney Perfusion After Transplantation by Intraoperative Fluorescence Angiography [Phase 2]
Phase 2 clinical trial assessing measurements of kidney perfusion after transplantation using intraoperative fluorescence angiography.
-
CLINICAL_TRIALS trial_result · 2020-03-05Clinical Trial Update: Study of Rituximab to Treat Chronic Renal Transplant Rejection [Phase 4]
A Phase 4 trial evaluating rituximab for chronic renal transplant rejection has been completed.
-
CLINICAL_TRIALS trial_result · 2020-03-02Clinical Trial Update: IRB 14-009240, Does CEUS Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys? [Phase 4]
Phase 4 clinical trial investigating whether contrast-enhanced ultrasound (CEUS) improves selection of biopsy sites in evaluating transplant…
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Dosing Requirements of Astagraf XL® in African American Kidney Transplant Recipients [Phase 4]
Phase 4 trial update describing dosing requirements of Astagraf XL in African American kidney transplant recipients.
-
CLINICAL_TRIALS trial_result · 2019-11-20Clinical Trial Update: Functional Genetic Variants Affecting Tacrolimus Trough Levels and Side Effects in Chinese Renal Transplantation.
A completed clinical trial examined how functional genetic variants influence tacrolimus trough levels and related side effects in Chinese k…
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy [Phase 2, Phase 3]
Clinical trial updates on Campath and calcineurin inhibitor reduction for chronic allograft nephropathy in kidney transplantation have compl…
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Pharmacogenetic Trial of Tacrolimus After Pediatric Transplantation [Phase 2]
Phase 2 pharmacogenetic trial of tacrolimus after pediatric transplantation completed; results posted.